View Enquiry List 
_cmqlp0q8.jpg)
_nqh35c8p.jpg)
_lsh25vfa.jpg)
_qo3o8c77.jpg)
<
>
Overview
Overview
Ready-to-use stabilized β-galactosidase mRNA
Concentration: 1.0 mg/mL in 1mM sodium Citrate (pH 6.4)
β-Gal mRNA has been designed to produce high expression level of β-galactosidase.
OZ Biosciences mRNAs are produced by in vitro transcription and stabilized at the 5’ end by modified nucleotides capping (Cap1). These mature mRNAs contain a poly(A) tail at the 3’ end and are also optimized to yield improved stability and performance.
β-Gal mRNAs:
-
#MRNA17 does not bear any additional nucleotide modifications.
-
#MRNA14 is modified with 5-methoxyuridine (5moU) to reduce innate immune responses.
-
#MRNA3 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response.
We recommend using our transfection reagents RmesFect or RmesFect Stem in order to reach high transfection efficiency and optimum protein expression level.
Size: 20 µg, 100µg and 1 mg
Storage: -80°C
mRNAs ARE SHIPPED WITH DRY ICE
| CATALOG NUMBER | UNIT SIZE |
| MRNA17-20 |
β-Gal mRNA 20 µg |
| MRNA17-100 |
β-Gal mRNA 100 µg |
| MRNA17-1000 |
β-Gal mRNA 1 mg |
| MRNA14-20 |
β-Gal mRNA (5moU) 20 µg |
| MRNA14-100 |
β-Gal mRNA (5moU) 100 µg |
| MRNA14-1000 |
β-Gal mRNA (5moU) 1 mg |
| MRNA3-20 |
β-Gal mRNA (N1-mψ) 20 µg |
| MRNA3-100 |
β-Gal mRNA (N1-mψ) 100 µg |
| MRNA3-1000 |
β-Gal mRNA (N1-mψ) 1 mg |
Applications
β-galactosidase (β-gal) mRNA, codes for a protein product of the bacterial LacZ gene. β-gal catalyzes the conversion of β-galactosides into monosaccharides. It is a common marker gene used to assess transfection efficiency.
